STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy ; volume:22 ; number:1 ; day:3 ; month:6 ; year:2024 ; pages:1-12 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (3.6.2024), 1-12, 12.2024
- Urheber
-
Rezabakhsh, Aysa
Sadaie, M. Reza
Ala, Alireza
Roosta, Yousef
Habtemariam, Solomon
Sahebnasagh, Adeleh
Khezri, Mohammad Rafi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-024-01680-0
- URN
-
urn:nbn:de:101:1-2408102121490.760491404728
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rezabakhsh, Aysa
- Sadaie, M. Reza
- Ala, Alireza
- Roosta, Yousef
- Habtemariam, Solomon
- Sahebnasagh, Adeleh
- Khezri, Mohammad Rafi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN
PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN
PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN
PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques